Brief: Virpax Pharmaceuticals On Track To Begin First-In-Human Trials Of Probudur In 2024
27/09/2023 14:21
Sept 27 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS INC- ON TRACK TO BEGIN
FIRST-IN-HUMAN
TRIALS OF PROBUDUR IN 2024
* VIRPAX PHARMACEUTICALS ANNOUNCES RESULTS OF PROBUDUR™ DOSE
ESCALATION STUDIES
Source text for Eikon: ID:nBw1ntZJXa
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study